The atypical antipsychotic clozapine has greater therapeutic efficacy than other medications in the treatment of schizophrenia, but the molecular mechanisms underlying clozapine's effects are poorly understood. The
a7-nicotinic acetylcholine receptor (nAchR) has been implicated in the genetics of schizophrenia. Moreover, the heavy smoking behavior of schizophrenics may be a form of self-medication. Clozapine induces early larval arrest in C. elegans. A genome-wide RNA interference (RNAi) screen for suppressors of clozapine-induced larval arrest yielded
acr-7, a homolog of the
a7-nAchR. We obtained an
acr-7 knockout strain and backcrossed this strain to wild type six times. We then confirmed our RNAi knockdown result by demonstrating that the
acr-7 knockout suppresses clozapine-induced larval arrest. Interestingly, our preliminary observations suggest that knockout of
acr-7 also suppresses clozapine-induced inhibition of locomotion in C. elegans. This finding indicates that
acr-7(lf) has pleiotropic effects and that
acr-7 may mediate both developmental and behavioral phenotypes of antipsychotic drugs in C. elegans. Therefore, detailed characterization of the genetic, cell biological, and behavioral roles of
acr-7 may provide insight into the effects of antipsychotic drugs on neuronal functions. Future experiments will include: 1) expression studies of
acr-7 in C. elegans using GFP fusion constructs; 2) additional developmental and behavioral experiments to test whether
acr-7 mediates the effects of antipsychotic drugs other than clozapine; 3) electrophysiological studies of
acr-7 in heterologous systems; 4) epistasis studies of
acr-7 and genes within the insulin sigaling pathway which also mediates clozapine's effects in C. elegans and mammals.